Drug intelligence / Profile preview

Cystex

Development stage
Unknown
Lead developer
Cystex
Modality
Small Molecules
Administration
Oral
01

Overview

Cystex is an oral over-the-counter combination urinary analgesic and antibacterial product used for temporary relief of symptoms associated with urinary tract infection and bladder irritation, including dysuria, urgency, and frequency. It contains two **small-molecule** active ingredients: methenamine, which serves as a urinary antibacterial agent by decomposing in acidic urine to generate formaldehyde with nonspecific antimicrobial activity, and sodium salicylate, a nonsteroidal anti-inflammatory drug that provides analgesic effects through cyclooxygenase inhibition and reduced prostaglandin synthesis. The product has been distributed under the Cystex brand by Cystex and labeled by Clarion Brands, and is marketed as a dual-action formula without urine-discoloring agents. Based on the provided context, its labeling has not been approved by the FDA and the product has not been found by FDA to be safe and effective.

Brand names
Cystex
Other names
methenamine + sodium salicylate
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Cystex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cystex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call